Johnson & Johnson vs. Oric Pharmaceuticals, Inc. Common Stock
Johnson & Johnson and Oric Pharmaceuticals, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| JNJ | ORIC | |
|---|---|---|
| Market Cap | $620.77 billion | $1.34 billion |
| Revenue (TTM) | — | — |
| Net Income (TTM) | — | $-140,351,000 |
JNJ leads on 1 of 1 size & scale factors.
Valuation
| JNJ | ORIC | |
|---|---|---|
| Price / Book | — | 3.52 |
JNJ and ORIC split the valuation factors evenly.
Profitability
| JNJ | ORIC | |
|---|---|---|
| Return on Equity | — | -36.81% |
JNJ and ORIC split the profitability factors evenly.
Risk & Sentiment
| JNJ | ORIC | |
|---|---|---|
| Short Interest | 0.67% | 0.65% |
ORIC leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, ORIC overview, ORIC financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.